Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2017

Published : Sep-2017

No. of Pages : 131

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Peripheral Transluminal Coronary Angioplasty Balloons Overview 8
3 Products under Development 9
3.1 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9
3.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10
3.3 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11
3.4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12
3.5 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13
3.6 Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14
4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products under Development by Companies 15
4.1 Peripheral Transluminal Coronary Angioplasty Balloons Companies - Pipeline Products by Stage of Development 15
4.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 17
5 Peripheral Transluminal Coronary Angioplasty Balloons Companies and Product Overview 18
5.1 3DT Holdings, LLC Company Overview 18
5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Aachen Resonance GmbH Company Overview 19
5.2.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Acrostak (Schweiz) AG Company Overview 20
5.3.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 AlviMedica Medical Technologies Inc. Company Overview 21
5.4.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Andramed GmbH Company Overview 22
5.5.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Atrium Medical Corp Company Overview 23
5.6.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Bolton Medical Inc Company Overview 24
5.7.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Boston Scientific Corp Company Overview 27
5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.9 Cordis Corp Company Overview 29
5.9.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Hatch Medical LLC Company Overview 30
5.10.1 Hatch Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Innovia LLC Company Overview 31
5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 iVascular SLU Company Overview 32
5.12.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Kaneka Corp Company Overview 33
5.13.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 Lithotech Medical Ltd Company Overview 35
5.14.1 Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Medinol Ltd Company Overview 36
5.15.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 Medtronic plc Company Overview 37
5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 37
5.17 Meril Life Sciences Pvt Ltd Company Overview 38
5.17.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
5.18 MicroPort Scientific Corp Company Overview 41
5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.19 Natec Medical Ltd Company Overview 43
5.19.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.20 Nexeon MedSystems Inc Company Overview 44
5.20.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.21 QT Vascular Ltd Company Overview 45
5.21.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
5.22 QualiMed Innovative Medizinprodukte GmbH Company Overview 49
5.22.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
5.23 Sahajanand Medical Technologies Pvt Ltd Company Overview 50
5.23.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 Terumo Corp Company Overview 51
5.24.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 The Spectranetics Corp Company Overview 52
5.25.1 The Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 52
5.26 VasoTech Inc. Company Overview 54
5.26.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
6 Peripheral Transluminal Coronary Angioplasty Balloons- Recent Developments 55
6.1 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 55
6.2 Aug 17, 2017: Firefighter PTCA Balloon Catheter Gains Regulatory Approval in Argentina 57
6.3 Aug 14, 2017: Foxtrot Pro Obtain Regulatory Approval in Malaysia 58
6.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 58
6.5 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 58
6.6 Aug 08, 2017: Nexeon Receives Research Grant from National Institutes of Health 62
6.7 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 63
6.8 Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 63
6.9 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 63
6.10 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 64
6.11 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 65
6.12 Jul 24, 2017: Firefighter PTCA Balloon Catheter Gains CFDA Approval 66
6.13 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 67
6.14 Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 67
6.15 Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 68
6.16 Jul 17, 2017: Getinge: Interim Report January - June 2017 68
6.17 Jul 07, 2017: MPSC New COO Glendy Wang on Board 68
6.18 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 69
6.19 Jun 24, 2017: Investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities 71
6.20 Jun 21, 2017: TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart Drug-Coated Coronary Balloon 71
6.21 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 72
6.22 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 72
6.23 Jun 06, 2017: OrbusNeich Announces FDA Clearance, Launch of Sapphire II PRO 73
6.24 Jun 06, 2017: OrbusNeich Announces FDA Clearance, Launch of Sapphire NC Plus Coronary Dilatation Catheter 73
6.25 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 74
6.26 May 23, 2017: MicroPort Listed as Enterprises Conforming to CSR Standards for Six Consecutive Years 77
6.27 May 12, 2017: Abbott Initiates Voluntarily Recall of Specific Lots of NC Trek RX Coronary Dilatation Catheter 77
6.28 May 12, 2017: Abbott Initiates Voluntarily Recall of NC Tenku RX PTCA Balloon Catheter 78
6.29 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 78
6.30 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 80
6.31 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 81
6.32 Apr 25, 2017: Getinge: Interim Report January-March 2017 82
6.33 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 82
6.34 Apr 20, 2017: Chief Financial Officer leaves Getinge 84
6.35 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 84
6.36 Mar 31, 2017: B. Braun continues its sales and earnings growth 84
6.37 Mar 30, 2017: MPSC Announces 2016 Annual Results 86
6.38 Mar 29, 2017: Resolutions at Getinge's Annual General Meeting 2017 87
6.39 Mar 23, 2017: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 88
6.40 Mar 21, 2017: The new Getinge logo - inspired by the star of life 92
6.41 Mar 20, 2017: Getinge establishes new brand structure and becomes a single brand company 92
6.42 Mar 15, 2017: Getinge to exhibit full product portfolio for Intensive Care Units at International Symposium on Intensive Care and Emergency Medicine (ISICEM) 92
6.43 Mar 10, 2017: Neovasc Announces TSX Symbol Change to NVCN 93
6.44 Feb 25, 2017: FOXTROT NC PTCA Balloon Catheter Gains Regulatory Approval in Mexico 93
6.45 Feb 23, 2017: Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million 94
6.46 Feb 22, 2017: Change in the B. Braun Management Board 94
6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 95
6.48 Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US 97
6.49 Feb 09, 2017: Terumo Announces Change of Executive Officers 98
6.50 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 99
6.51 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 100
6.52 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 101
6.53 Jan 31, 2017: Terumo Opens a Branch in Yangon 103
6.54 Jan 26, 2017: Getinge Year-End Report January-December 2016 103
6.55 Jan 18, 2017: Neovasc Announces Update in Litigation with CardiAQ 103
6.56 Jan 15, 2017: Getinge Group to exhibit complete product portfolio at Arab Health 104
6.57 Jan 11, 2017: OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Balloon 104
6.58 Jan 11, 2017: Spectranetics Names Scott Hutton as General Manager, Vascular Intervention 105
6.59 Jan 10, 2017: US Endovascular Announces John F. Vacha & Paul A. Tyska Join The Partnership 106
6.60 Dec 28, 2016: MicroPort was selected as a pilot project of Patent Alliance of Enterprises in Shanghai Zhangjiang National Innovation Demonstration Zone 106
6.61 Dec 19, 2016: MicroPort Endovascular Received CE Mark Approval for Hercules Balloon Dilation Catheter 107
6.62 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 107
6.63 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 108
6.64 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 109
6.65 Nov 16, 2016: iVascular announces that NC Xperience - non-compliant dilatation catheter - has received CE mark approval 112
6.66 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 113
6.67 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 113
6.68 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 114
6.69 Nov 03, 2016: Mattias Perjos appointed President and CEO of Getinge Group 116
6.70 Oct 27, 2016: Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million 117
6.71 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 118
6.72 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 119
6.73 Oct 18, 2016: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge 121
6.74 Oct 18, 2016: Getinge Interim Report January-September 2016 122
6.75 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 125
6.76 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit 125
6.77 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 126
7 Appendix 128
7.1 Methodology 128
7.2 About GlobalData 131
7.3 Contact Us 131
7.4 Disclaimer 131

1.1 List of Tables
Table 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9
Table 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10
Table 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11
Table 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12
Table 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13
Table 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14
Table 7: PTCA Balloons Companies - Pipeline Products by Stage of Development 15
Table 8: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 17
Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 18
Table 10: Coronary Post-Dilatation Catheter - Product Status 18
Table 11: Coronary Post-Dilatation Catheter - Product Description 18
Table 12: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
Table 13: VIAR - Product Status 19
Table 14: VIAR - Product Description 19
Table 15: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 20
Table 16: PTCA Balloon - Product Status 20
Table 17: PTCA Balloon - Product Description 20
Table 18: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 19: ProHP - Product Status 21
Table 20: ProHP - Product Description 21
Table 21: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 22
Table 22: Zero-Profile PTCA Balloon - Product Status 22
Table 23: Zero-Profile PTCA Balloon - Product Description 22
Table 24: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 23
Table 25: Coronary Stent Balloon Catheter - Product Status 23
Table 26: Coronary Stent Balloon Catheter - Product Description 23
Table 27: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 28: Flash PTCA - Product Status 24
Table 29: Flash PTCA - Product Description 24
Table 30: Runner PTCA Balloon Catheter - Product Status 25
Table 31: Runner PTCA Balloon Catheter - Product Description 25
Table 32: Runner Slim PTCA - Product Status 25
Table 33: Runner Slim PTCA - Product Description 26
Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 27
Table 35: 1.2 Zulu PTCA - Product Status 27
Table 36: 1.2 Zulu PTCA - Product Description 27
Table 37: NC Zulu PTCA Post-Dilatation Catheter - Product Status 28
Table 38: NC Zulu PTCA Post-Dilatation Catheter - Product Description 28
Table 39: Zulu PTCA Pre-Dilatation Catheter - Product Status 28
Table 40: Zulu PTCA Pre-Dilatation Catheter - Product Description 28
Table 41: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 42: Next Generation EMPIRA PTCA Balloon - Product Status 29
Table 43: Next Generation EMPIRA PTCA Balloon - Product Description 29
Table 44: Hatch Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30
Table 45: Hydra Bifurcated Coronary Balloon Catheter - Product Status 30
Table 46: Hydra Bifurcated Coronary Balloon Catheter - Product Description 30
Table 47: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31
Table 48: Low Profile Angioplasty Balloon Catheter - Product Status 31
Table 49: Low Profile Angioplasty Balloon Catheter - Product Description 31
Table 50: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 32
Table 51: Scoring Balloon - Product Status 32
Table 52: Scoring Balloon - Product Description 32
Table 53: Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 33
Table 54: Ikazuchi Zero - Product Status 33
Table 55: Ikazuchi Zero - Product Description 34
Table 56: Raiden 3 - Product Status 34
Table 57: Raiden 3 - Product Description 34
Table 58: Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
Table 59: Scoring Balloon - Product Status 35
Table 60: Scoring Balloon - Product Description 35
Table 61: Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 62: Gallant PTCA Balloon Catheter - Product Status 36
Table 63: Gallant PTCA Balloon Catheter - Product Description 36
Table 64: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 65: Euphora Drug Coated Balloon - Product Status 37
Table 66: Euphora Drug Coated Balloon - Product Description 37
Table 67: Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
Table 68: MeRes100 - Product Status 38
Table 69: MeRes100 - Product Description 38
Table 70: Meril Life Sciences Pvt Ltd - Ongoing Clinical Trials Overview 39
Table 71: MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions (MeRes-1 Extend) 40
Table 72: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 41
Table 73: Hercules-D - Product Status 41
Table 74: Hercules-D - Product Description 41
Table 75: Ryfle PTCA Balloon - Product Status 42
Table 76: Ryfle PTCA Balloon - Product Description 42
Table 77: Ryfle PTCA Balloon Catheter - Product Status 42
Table 78: Ryfle PTCA Balloon Catheter - Product Description 42
Table 79: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Table 80: NATEC Angioplasty Balloon - Product Status 43
Table 81: NATEC Angioplasty Balloon - Product Description 43
Table 82: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 83: Nanocomposite-Based Polymer Balloon - Product Status 44
Table 84: Nanocomposite-Based Polymer Balloon - Product Description 44
Table 85: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
Table 86: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Status 45
Table 87: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Description 45
Table 88: Silk PTCA Balloon Catheter - Product Status 46
Table 89: Silk PTCA Balloon Catheter - Product Description 46
Table 90: QT Vascular Ltd - Ongoing Clinical Trials Overview 47
Table 91: Chocolate Touch PTCA Coronary Drug Coated Balloon - Clinical Study Evaluating the Chocolate Touch PTCA Coronary Drug-coated Balloon 48
Table 92: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
Table 93: Biodegradable Balloon - Product Status 49
Table 94: Biodegradable Balloon - Product Description 49
Table 95: Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
Table 96: Advanced Balloon Catheter - Product Status 50
Table 97: Advanced Balloon Catheter - Product Description 50
Table 98: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 51
Table 99: PTCA Balloon - Product Status 51
Table 100: PTCA Balloon - Product Description 51
Table 101: The Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 52
Table 102: CardioSculpt Valvuloplasty Scoring Balloon - Product Status 52
Table 103: CardioSculpt Valvuloplasty Scoring Balloon - Product Description 52
Table 104: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status 53
Table 105: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description 53
Table 106: VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
Table 107: DirectBalloon - Product Status 54
Table 108: DirectBalloon - Product Description 54
Table 109: Glossary 130

1.2 List of Figures
Figure 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9
Figure 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10
Figure 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11
Figure 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12
Figure 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13
Figure 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027